Specialty Focused Recordings: Neuro-Oncology-Malignant BT Webinar

Video Transcription

Video Summary

The webinar reviews longitudinal, multidisciplinary care for patients with malignant brain tumors, emphasizing that support must extend beyond surgery, radiation, and chemotherapy. Tumors vary by histology, molecular profile, location, and grade; these factors influence symptoms, treatment choices, and prognosis. The speaker highlights the importance of understanding updated WHO classifications and markers such as IDH mutations, MGMT promoter status, and 1p/19q codeletion.<br /><br />Nursing care includes focused neurologic assessment, patient and family education, and monitoring for treatment effects and complications. Key issues include peritumoral edema and steroid side effects, seizures and antiepileptic medications, postoperative infection or CSF leaks, fatigue, and cognitive dysfunction. Nurses can coordinate referrals to rehabilitation, neuropsychology, social work, counseling, and support groups, while also addressing caregiver burden and practical needs.<br /><br />The presentation stresses clear communication, multidisciplinary coordination, and ongoing access to a healthcare team. Advance care planning, surrogate decision-makers, spiritual needs, and palliative or hospice care should be discussed as appropriate. The central message is to advocate continuously for patients and caregivers throughout the disease course.

Keywords

malignant brain tumors

multidisciplinary care

WHO classification

IDH mutations

MGMT promoter status

1p/19q codeletion

neurologic assessment

palliative care

caregiver support